Physician profile
Darlene J Elias
NPI 1528167558
$2,279.43
in general payments reported to CMS, 2019-2025
19 companies · $79.22 in 2025
The $79.22 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $957 · 2020: $218 · 2021: $341 · 2022: $539 · 2023: $88.84 · 2024: $56.31 · 2025: $79.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $224.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $914.54 | 2019-2025 | Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $404.48 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $202.04 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $129.58 | 2019-2021 | |
| Pfizer INC. | $124.42 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $98.42 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $88.26 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $60.92 | 2019-2021 | |
| Insmed, INC. | $41.52 | 2019 | |
| Gilead Sciences, INC. | $40.23 | 2019 | |
| Genzyme Corporation | $29.36 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $22.13 | 2022 | |
| Mylan Specialty L.P. | $21.46 | 2019 | |
| United Therapeutics Corporation | $21.40 | 2019 | |
| Amgen INC. | $18.66 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $18.23 | 2022 | |
| Grifols USA, LLC | $17.81 | 2019 | |
| Genentech USA, INC. | $13.32 | 2020 | |
| Shire North American Group INC | $12.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darlene Elias listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.